In addition, the inhibition of the toll-like receptor 9 (TLR9) present in the list has been recognized to promote a kind of cardiac inflammation using a mouse model of TLR9-deficient (TLR9-D) [44]. This evidence concerns the gene TLR9 and inflammation.